MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock
$3,250K
something is missing
$445K
Payments on insurance
financing debt
-$109K
(-236.25%↓ Y/Y)
Payment of equity
issuance costs
-$104K
(-158.43%↓ Y/Y)
Proceeds from issuance of
common stock under...
$17K
(466.67%↑ Y/Y)
Net cash provided by
(used in) financing...
$171K
(167.32%↑ Y/Y)
Canceled cashflow
$3,754K
Net decrease in
cash, cash...
-$3,619K
(17.82%↑ Y/Y)
Canceled cashflow
$171K
Stock-based compensation
and related charges
$8,854K
(6315.94%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,789K
(47.85%↑ Y/Y)
Operating lease
liabilities
$90K
(236.36%↑ Y/Y)
Proceeds from the
exercise of warrants
-$3,754K
(-375500.00%↓ Y/Y)
Net cash used in
operating activities
-$3,790K
(8.67%↑ Y/Y)
Canceled cashflow
$10,733K
Net loss
-$12,292K
(-145.15%↓ Y/Y)
Accrued compensation
and benefits
-$922K
(-73.96%↓ Y/Y)
Accounts receivable
$500K
Prepaid and other
current assets and other...
$378K
(2000.00%↑ Y/Y)
Recurring fair value
measurements of liabilities
$330K
(3566.67%↑ Y/Y)
Non-cash operating lease
expense
-$84K
(-235.48%↓ Y/Y)
Write-off of deferred
equity issuance costs
-$75K
(-200.00%↓ Y/Y)
Back
Back
Cash Flow
PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. (PALI)
source: myfinsight.com